GlassScriptPhysician profile
John Jason Robinson
NPI 1376521468
$2,588.10
in general payments reported to CMS, 2019-2025
31 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $251 · 2021: $898 · 2022: $268 · 2023: $346 · 2024: $161 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $780.10 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $208.74 | 2019-2025 | |
| Procept Biorobotics Corporation | $200.97 | 2023-2025 | Aquabeam Robotic System |
| Axonics, INC. | $157.22 | 2021-2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $137.08 | 2020-2021 | |
| Astellas Pharma US INC | $101.64 | 2020-2022 | |
| Smith+Nephew, INC. | $92.34 | 2019-2025 | Stravix Pl, Stravix |
| Urogen Pharma, INC. | $90.74 | 2024-2025 | |
| Angiodynamics, INC. | $81.45 | 2023 | Nanoknife |
| Sumitomo Pharma America, INC. | $79.45 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $77.96 | 2020-2025 | Lupron Depot |
| Neotract INC. | $73.92 | 2019-2020 | |
| Janssen Biotech, INC. | $70.43 | 2019 | |
| Amgen INC. | $66.32 | 2019-2024 | Repatha, Otezla |
| Urovant Sciences INC | $47.25 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $35.42 | 2022-2023 | Xiaflex |
| Agiliti Health, INC. | $31.04 | 2024 | Endocare Cryocare Cs System, Sonablate Hifu |
| Myovant Sciences INC. | $30.51 | 2021-2022 | |
| Medtronic USA, INC. | $26.97 | 2020 | |
| Accord Healthcare, INC. | $21.77 | 2023 | |
| Novo Nordisk INC | $20.75 | 2024 | Wegovy |
| Convatec INC. | $20.58 | 2023 | |
| Kerecis Limited | $19.71 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.67 | 2025 | |
| Olympus America INC. | $15.75 | 2025 | Itind System |
| Calyxo, INC. | $15.56 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $15.26 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $13.65 | 2019 | |
| Coloplast Corp | $13.59 | 2019 | |
| Bard Access Systems, INC. | $12.37 | 2019 | |
| Intuitive Surgical, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.